MIMEDX (NASDAQ: MDXG) awards 50,913 restricted shares to director Todd Newton

Rhea-AI Filing Summary

MIMEDX GROUP, INC. director Todd Newton received an annual restricted stock award, acquiring 50,913 shares of common stock at a reference price of $3.64 per share as director compensation. The grant is exempt under Rule 16b-3 and will vest upon the earlier of 12 months or the next shareholder meeting. Following this award, Newton directly holds 463,684 shares of MIMEDX common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Newton Todd

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	50,913	$3.64	$185K

Holdings After Transaction: Common Stock — 463,684 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock grant: 50,913 shares Reference price per share: $3.64 per share Post-transaction holdings: 463,684 shares +2 more

5 metrics

Restricted stock grant 50,913 shares Annual grant to non-employee director Todd Newton

Reference price per share $3.64 per share Grant/award acquisition price for restricted stock

Post-transaction holdings 463,684 shares Newton’s direct MIMEDX common stock holdings after grant

Transaction code A Grant, award, or other acquisition of common stock

Vesting condition Earlier of 12 months or next shareholder meeting Time-based vesting for restricted stock award

Key Terms

restricted stock, Rule 16b-3, non-employee directors, vests, +1 more

5 terms

restricted stock financial

"Represents annual restricted stock grant to non-employee directors."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Rule 16b-3 regulatory

"Grant is exempt under Rule 16b-3."

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

non-employee directors financial

"Represents annual restricted stock grant to non-employee directors."

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

vests financial

"The award vests upon the earlier of 12 months or the next meeting of shareholders."

Form 4 regulatory

"reported under a Form 4 insider transaction filing."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Newton Todd

(Last) (First) (Middle)

1775 WEST OAK COMMONS COURT

(Street)

MARIETTA GEORGIA 30062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		50,913(1)	A	$3.64	463,684	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.

Remarks:

	/s/ William F. Hulse as attorney in fact for K. Todd Newton	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MIMEDX (MDXG) report for Todd Newton?

MIMEDX reported that director Todd Newton received an annual restricted stock award of 50,913 common shares. This is a compensation-related grant, not an open-market purchase, and was recorded at a reference price of $3.64 per share under a Form 4 filing.

Is the Todd Newton stock grant at MIMEDX (MDXG) a routine award?

Yes. The filing describes the 50,913-share grant as an annual restricted stock grant to a non-employee director. Such awards are a standard form of equity compensation and are exempt under Rule 16b-3, indicating a routine, board-approved compensation practice.

When do Todd Newton’s MIMEDX (MDXG) restricted shares vest?

The award vests upon the earlier of 12 months from grant or the next meeting of shareholders. This time-based vesting schedule aligns Newton’s compensation with continued board service and the upcoming shareholder meeting, as disclosed in the Form 4 footnote.

How many MIMEDX (MDXG) shares does Todd Newton hold after the grant?

After the reported restricted stock grant, Todd Newton directly holds 463,684 shares of MIMEDX common stock. This figure reflects his position following the 50,913-share award and is disclosed in the Form 4 as the total shares following the transaction.

Was the MIMEDX (MDXG) director stock grant an open-market purchase?

No. The Form 4 shows transaction code “A,” indicating a grant or award acquisition, not an open-market purchase. The shares were issued as an annual restricted stock grant to a non-employee director rather than bought on the open market.